Quarterly Consolidated Balance Sheet

Kringle Pharma,Inc. - Filing #7592098

Concept As at
2022-06-30
As at
2021-09-30
Quarterly consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
2,448,081,000 JPY
2,137,520,000 JPY
Merchandise and finished goods
88,413,000 JPY
88,413,000 JPY
Raw materials and supplies
339,932,000 JPY
226,681,000 JPY
Other
12,305,000 JPY
20,610,000 JPY
Current assets
3,012,543,000 JPY
2,634,594,000 JPY
Non-current assets
Property, plant and equipment
JPY
JPY
Property, plant and equipment
Investments and other assets
2,694,000 JPY
1,031,000 JPY
Investments and other assets
Non-current assets
2,694,000 JPY
1,031,000 JPY
Assets
3,015,238,000 JPY
2,635,625,000 JPY
Liabilities
Current liabilities
Income taxes payable
1,117,000 JPY
1,490,000 JPY
Other
8,353,000 JPY
5,538,000 JPY
Current liabilities
45,402,000 JPY
127,196,000 JPY
Non-current liabilities
Asset retirement obligations
2,305,000 JPY
2,278,000 JPY
Non-current liabilities
256,679,000 JPY
2,278,000 JPY
Liabilities
302,082,000 JPY
129,475,000 JPY
Net assets
Shareholders' equity
Share capital
307,708,000 JPY
51,820,000 JPY
Capital surplus
3,011,429,000 JPY
2,755,541,000 JPY
Retained earnings
-608,005,000 JPY
-301,166,000 JPY
Treasury shares
-75,000 JPY
-45,000 JPY
Shareholders' equity
2,711,056,000 JPY
2,506,149,000 JPY
Share acquisition rights
2,099,000 JPY
JPY
Net assets
2,713,156,000 JPY
2,506,149,000 JPY
Liabilities and net assets
3,015,238,000 JPY
2,635,625,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.